Kenneth C. Frazier Elected to ExxonMobil Board

May 27, 2009 - 01:52 PM EDT

Dateline:

IRVING, Texas

Public Company Information:

NYSE:
XOM

IRVING, Texas--(BUSINESS WIRE)--Exxon Mobil Corporation (NYSE:XOM) announced today that shareholders elected Kenneth C. Frazier to its board of directors. Mr. Frazier is currently Executive Vice President and President, Global Human Health, at Merck & Co., Inc.

With Mr. Frazier’s election, the ExxonMobil board stands at ten directors, nine of whom are non-employee directors. Mr. Frazier will serve on the Board Affairs and Public Issues and Contributions Committees.

Mr. Frazier was appointed to his current position in 2007. In this role, he leads marketing and sales functions for Merck's pharmaceutical and vaccine businesses worldwide.

Since joining Merck in 1992, Mr. Frazier has held a number of key leadership positions including serving as Senior Vice President and General Counsel from 1999 to 2006. Prior to Merck, Mr. Frazier was a partner with the Philadelphia firm of Drinker Biddle & Reath. Mr. Frazier has been recognized with multiple awards for his personal pro bono legal work.

Mr. Frazier, 54, earned a B.A. in Political Science from Pennsylvania State University in 1975 and a J.D. from Harvard Law School in 1978.

Exxon Mobil Corporation

Globally, Exxon Mobil Corporation is the world's largest publicly quoted oil and gas company and the world's largest corporation in terms of market capitalization. Worldwide the company and its subsidiaries produce approximately 4 million oil-equivalent barrels of energy resources every day from some 1600 fields and operate or market products on 6 continents. Exxon Mobil Corporation is also the world's largest non-government marketer of natural gas and in our global downstream business the company has interests in 38 refineries in 21 countries and over 32,000 service stations world-wide.

Contact:

Exxon Mobil Corporation
Rob Young, 972-444-1108